Abstract
purpose. To test the hypothesis that alterations of RNFL birefringence precede changes in RNFL thickness in an experimental model of RGC injury and, secondarily, to determine the time course of RGC functional abnormalities relative to RNFL birefringence and thickness changes.
methods. RNFL birefringence was measured by scanning laser polarimetry (GDx VCC; Carl Zeiss Meditec, Inc., Dublin, CA). RNFL thickness was measured by spectral domain optical coherence tomography (SD-OCT, Spectralis HRA+OCT; Heidelberg Engineering, GmbH, Heidelberg, Germany). Retinal function was assessed by three forms of electroretinography (ERG): slow-sequence multifocal (mf)ERG (VERIS; EDI, San Mateo, CA); pattern-reversal (P)ERG (Utas-E3000; LKC Technologies, Inc. Gaithersburg, MD); and photopic full-field flash (ff)ERG (Utas-E3000; LKC Technologies). All measurements were obtained in both eyes of four adult rhesus macaque monkeys (Macaca mulatta) during two baseline sessions, and again 1 week and 2 weeks after unilateral optic nerve transection (ONT).
results. ONT was successfully completed in three subjects. RNFL birefringence declined by 15% 1 week after ONT (P = 0.043), whereas there was no significant change in RNFL thickness (+1%, P = 0.42). Two weeks after ONT, RNFL retardance had declined by 39% (P = 0.018), whereas RNFL thickness had declined by only 15% (P = 0.025). RGC functional abnormalities were present 1 week after ONT, including decreased amplitudes relative to baseline of the mfERG high-frequency components (−65%, P = 0.018), the PERG N95 component (−70%, P = 0.007), and the photopic negative response of the ffERG (−44%, P = 0.005).
conclusions. RNFL birefringence declined before and faster than RNFL thickness after ONT. RGC functional abnormalities were present 1 week after ONT, when RNFL thickness had not yet begun to change. RNFL birefringence changes after acute RGC injury are associated with RGC dysfunction. Together, they reflect RGC abnormalities that precede axonal caliber changes and loss.
Previous studies have shown that cytoskeletal components and their tertiary structure within retinal ganglion cell (RGC) axons cause the retinal nerve fiber layer (RNFL) to exhibit the optical property of form birefringence.
1 2 3 This idea is supported both by theoretical analyses
1 2 and by evidence demonstrating that RNFL birefringence declines rapidly after chemical disruption of cytoskeletal components, microtubules (MT) in particular, in situ
3 or in vivo.
4 This finding, in turn, has clinical relevance because cytoskeletal abnormalities may develop in diseases such as glaucoma before the death of RGCs. For example, in experimental models of RGC injury such as optic nerve transection (ONT) or crush, there is a delay among most surviving RGCs before axonal caliber begins to decline,
5 which is preceded by changes in cytoskeletal protein content and mRNA.
6 7 Abnormalities of cytoskeletal proteins such as neurofilament (NF) have also been demonstrated in experimental models of glaucoma
8 9 10 and may represent a mechanism of susceptibility.
11 Thus, it is possible that measurement of RNFL birefringence can be used to detect early-stage cellular dysfunction and/or to predict subsequent risk of progression and permanent loss.
3 12
RNFL birefringence can be measured clinically using scanning laser polarimetry (SLP)
12 13 14 or polarization sensitive optical coherence tomography.
15 16 17 18 Using SLP, Mohammadi et al.
19 found that measures of RNFL birefringence are an independent predictor of future vision loss in patients with suspected glaucoma who began the study with normal SAP visual fields, regardless of their age, IOP, or optic disc appearance. Although this is consistent with the hypothesis that cytoskeletal abnormalities were present before subsequent progressive changes in optic nerve structure or function, the technique of SLP measures retardance, which is a function of both RNFL birefringence and RNFL thickness.
3 12 13 17 18 20 21 Thus, it is possible that, in Mohammadi et al.,
19 the RNFL thickness changes were present at baseline and predictive of future progression of glaucoma.
22
The primary purpose of the present study was to test the hypothesis that alterations of RNFL birefringence precede changes in RNFL thickness in an experimental model of RGC injury. The secondary purpose was to determine the time course of RGC functional abnormalities relative to RNFL birefringence and RNFL thickness changes.
All experimental procedures began with induction of general anesthesia using ketamine (15 mg/kg IM), along with a single SC injection of atropine sulfate (0.05 mg/kg). Animals were then intubated and breathed 100% oxygen for retinal function testing by electroretinography (ERG), during which anesthesia was maintained with a combination of ketamine (5 mg/kg/h IV) and xylazine (0.8 mg/kg/h IM). On completion of retinal function testing, ketamine-xylazine administration was discontinued, and isoflurane gas (1%–3%) was mixed with oxygen to provide anesthesia during structural imaging of the retina and optic nerve head (ONH). Isoflurane (1%–1.5%) was also used to provide anesthesia during optic nerve transection surgery.
During all procedures, heart rate, and arterial oxyhemoglobin saturation were monitored continuously (Propaq Encore model 206EL; Protocol Systems, Inc., Beaverton, OR) and maintained above 75 minutes−1 and 95%, respectively. Body temperature was maintained with a warm-water heating pad set at 37°C.
Multifocal ERGs.
mfERGs were recorded with a commercial system (VERIS; ver. 4; EDI, San Mateo, CA). Residual refractive error was measured by retinoscopy for the test distance (25 cm) and corrected to the nearest half diopter. The mfERG stimulus was presented on a 21-in. monochrome monitor with a 75-Hz refresh rate. An initial set of brief recordings (2 minutes each) was used to center the stimulus on the visual axis such that the foveal and “blind spot” responses were positioned appropriately within the response array.
The mfERG stimulus consisted of 103 unscaled hexagonal elements subtending a total field size of ∼55°. The luminance of each hexagon was independently modulated between dark (1 cd/m2) and light (200 cd/m2), according to a pseudorandom, binary m-sequence. Stimulus luminance was measured with a calibrated spot photometer (SpectraScan PR-650; Photo Research, Chatsworth, CA). The temporal stimulation rate was slowed by insertion of seven dark frames into each m-sequence step (7F). The m-sequence exponent was set to 12; thus, the total duration of each recording was 7 minutes, 17 seconds. The signals were amplified (gain = 100,000), band-pass filtered (10–300 Hz; with an additional 60-Hz line filter), sampled at 1.2 kHz (i.e., sampling interval, 0.83 ms), and digitally stored for subsequent off-line analyses. Two such recordings were obtained for each eye at each time point and averaged.
From the average of the two recordings at each time point, a subset of local responses was exported for further analyses.
Figure 1Ashows the stimulus locations of this subset, consisting of the central part of the array where RGC contributions are largest.
24 25 The response from the central stimulus element (marked with a C) and those from the two surrounding concentric rings were evaluated: locations are numbered 1 to 6 around the first ring and 1 to 12 around the second ring.
Each local mfERG response was band-passed filtered (−3 dB at 65 and 250 Hz) to extract the high-frequency components (HFCs;
Fig. 1B ). The low-frequency component (LFC) of each response was represented as the raw response minus the HFC. The amplitude of the HFC was calculated as the root mean square (RMS) for the epoch between 0 to 80 ms of each filtered record. Peak amplitudes for LFC features
(Fig. 1B)were quantified as follows: the first negative feature (N1) was calculated as the maximum negative excursion from baseline in the epoch up to 30 ms; the amplitude of the first positivity (P1) was calculated as the voltage difference between the maximum peak and the N1 trough; and the second negativity (N2) was calculated as the difference between baseline and the minima from 30 to 80 ms.
Pattern-Reversal ERGs.
Full-Field Flash ERGs.
RNFL Birefringence.
RNFL Thickness.
Thickness measurements were obtained by spectral-domain optical coherence tomography (SD-OCT; Spectralis HRA+OCT instrument (Heidelberg Engineering, GmbH, Heidelberg, Germany). The optical resolution of the instrument is ∼7 μm axially (depth) and ∼14 μm transversely. The depth of each A-scan is 1.8 mm and consists of 512 pixels, providing a digital depth sampling of 3.5 μm per pixel. Each B-scan spans 15° and consists of 768 A-scans providing a digital transverse sampling of 5 μm per pixel (in an emmetropic human eye with average axial length). For this experiment, volume scans consisting of 145 horizontal B-scan sections were centered on the ONH. Each B-scan in the volume spanned 15° horizontally and the block of 145 B-scans spanned 15° vertically (thus, B-scans were separated by 0.1034°, vertically). Radially oriented B-scans were also acquired with 48 sections arranged in a star pattern centered on the ONH.
A real-time eye-tracking system measures eye movements and provides feedback to the SD-OCT scanning system to stabilize the retinal position of the B-scan. This system thus enables sweep averaging at each B-scan location to reduce speckle noise. For this experiment, nine sweeps were averaged for each B-scan.
RNFL thickness measurements were derived from manual delineation of anterior (internal limiting membrane) and posterior borders along a single A-scan at the appropriate eccentricity within each radial B-scan. This eccentricity was chosen to correspond with the location of the RNFL birefringence measurement acquired by SLP. This eccentricity was determined to be equivalent to “1400 μm” from the center of the ONH, as indicated by a ruler within the OCT visualization software. In converting angular span to linear distance, the SD-OCT instrument assumes an emmetropic human eye with average axial length. This dimension translates to ∼1120 μm on the macaque retina (assuming 19 mm in axial length)
28 29 and thus corresponds to the locus of SLP birefringence measurements.
Figure 4provides an example of the RNFL thickness measurement method. The radial B-scans were used for all RNFL thickness measurements reported herein. Cross-validation was performed by using the horizontal volume scans in which measurements at the same eccentricity and polar angle differed by ≤5 μm (∼1 pixel) from those made within radial B-scans.
Confocal Scanning Laser Tomography.
Stereoscopic Photographs.
Digital Video Fluorescein Angiography.
Intraocular Pressure.
Optic Nerve Transection.
The results of this study demonstrate that RNFL birefringence decreased 1 week after ONT, while RNFL thickness had not yet changed. By the second week after ONT, RNFL thickness had declined by 15%, while the decrease in retardance measured by SLP was more than twice that amount (39%), suggesting that RNFL birefringence (retardance per unit thickness) had declined further still.
3 12 13 17 18 20 21 It is thought that form birefringence of the RNFL is due to the orderly structural array of thin cylindrical cytoskeletal components within RGC axons such as MT and NF.
1 2 3 Previous studies have shown that RNFL birefringence declines rapidly after chemical disruption of MT, a component of the RGC cytoskeleton, in situ
3 or in vivo.
4 Thus, it has been suggested that measurements of RNFL birefringence could provide a sensitive indicator of compromised cytoskeleton within RGC axons.
3 12 The results of this study indicate that there is a stage during RGC degeneration where the axonal cytoskeleton has become abnormal enough to result in altered RNFL birefringence and that this stage precedes thinning of the axon bundles of the peripapillary RNFL.
This intermediate stage observed in this study in response to a relatively acute experimental injury (ONT) may be common to other forms of RGC injury, such as in glaucoma. For example, it has been suggested that reduced gene NF expression represents a general response to RGC injury.
7 Moreover, abnormalities of cytoskeletal proteins such as NF and MT have been demonstrated in experimental models of glaucoma
8 11 and after short-term elevation of IOP.
9 10 36 37 This finding is important partly because critical functional capabilities depend on intact MT, as they provide the “tracks” on which most active axoplasmic transport takes place.
38 39 40 Interruption of axoplasmic transport has been proposed as a fundamental pathophysiological process in glaucoma and has been demonstrated to occur during acutely and chronically elevated IOP states in several mammalian species.
9 10 36 37 41 42 43 44 Chemical disruption of MT by colchicine or vinblastine halts axonal transport in RGCs.
38 39 Therefore, MT disruption may not only be caused by elevated IOP, but also leads to further abnormalities of axoplasmic transport, perhaps resulting in a vicious cycle. Further studies are under way to determine whether a similar intermediate stage of RGC degeneration, in which RNFL birefringence precedes changes in RNFL thickness, also occurs during experimental glaucoma. Initial results in four animals suggest that it does (Fortune B, et al.
IOVS 2008;49:ARVO E-Abstract 3761).
The secondary purpose of this study was to determine whether abnormalities of RGC function are associated with the intermediate stage of degeneration (i.e., whether altered function also precedes RNFL thinning after ONT). Three different modes of ERG testing were used to monitor retinal function. The pattern of results for each mode is consistent with loss of RGC function predominantly, although there was some evidence that mild disruption of function of other retinal elements may also have occurred. The photopic ffERG revealed a greater effect on the PhNR than on the a-wave, b-wave, or OPs. The PhNR is thought to be dependent on intact RGC function while the a-wave and b-wave represent responses of more distal retinal generators.
45 46 47 The N95 component of the PERG was affected more than the P50 component during the second week post-ONT. This pattern, again, is consistent with loss of predominantly inner retinal function, particularly of RGCs.
48 The mfERG HFCs were affected by ONT to a greater extent than the LFC features N1, P1, and N2. This pattern is also indicative of abnormal RGC function.
23 24 25 49 50 It is possible that restricting the band-pass filter to isolate only the highest frequency content of these mfERG responses could provide an even more sensitive indicator and greater dynamic range over which to study effects on RGC function.
50
To the extent that the photopic ffERG a-wave represents cone photoreceptor signaling,
47 51 52 the results of this study suggest that there was a relatively mild, transient effect of ONT on function of the outer retina (although not statistically significant given the relatively small sample size and variability of the a-wave amplitude). The 10% reduction in a-wave amplitude 1 week after ONT, which seems to have resolved to 96% of baseline values by the second week after ONT, may have been due to the trauma associated with the orbitotomy. For the conditions of this study (background and flash intensities and chromaticities, criterion time of a-wave amplitude measurement), it is likely that the a-wave amplitude measurement reflects a relatively large contribution from hyperpolarizing second-order retinal neurons such as horizontal and off cone bipolar cells in addition to cone photoreceptor responses.
51 53 Nonetheless, the results suggest that any mild outer retinal functional changes recovered almost completely by the second week after ONT.
In summary, the results of this study demonstrate that RNFL birefringence declines before and faster than RNFL thickness in the weeks after experimental injury of RGCs by ONT. This result suggests that disruption of the RGC cytoskeleton precedes RNFL thinning after injury. Abnormalities of RGC function were present along with decreased RNFL birefringence 1 week after ONT, when RNFL thickness and ONH topography were still normal. Collectively, the results are indicative of a stage of RGC dysfunction preceding changes in RNFL thickness. Further studies are under way to determine whether similar intermediate stages of degeneration and abnormal function are detectable in experimental glaucoma before changes in RNFL thickness. Finally, although the results reported herein were robust to rigorous statistical analysis and similar in all three subjects, the conclusions are based on a small sample size of three, which should be considered a limitation of this study.
Supported by National Eye Institute R01-EY011610 (CFB); the Glaucoma Research Foundation (BF); the Legacy Good Samaritan Foundation; Heidelberg Engineering, GmbH, Heidelberg, Germany (equipment); and Carl Zeiss Meditech, Inc. (equipment).
Submitted for publication May 6, 2008; revised June 2, 2008; accepted August 21, 2008.
Disclosure:
B. Fortune, Carl Zeiss Meditec, Inc. (F);
G.A. Cull, None;
C.F. Burgoyne, Heidelberg Engineering, GmbH (F)
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked “
advertisement” in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Corresponding author: Brad Fortune, Devers Eye Institute, 1225 NE Second Avenue, Portland, OR 97232;
[email protected].
Table 1. Study Subjects’ Age, Weight, Sex, and Intraocular Pressure
Table 1. Study Subjects’ Age, Weight, Sex, and Intraocular Pressure
ID | Age (y) | Weight (kg) | Sex | Intraocular Pressure | | | | | | | |
| | | | Baseline 1 | | Baseline 2 | | 1 wk Post ONT | | 2 wk Post ONT | |
| | | | OD | OS | OD | OS | OD | OS | OD | OS |
ONT1 | 10 | 5.0 | F | 15.7 | 14.3 | 10.0 | 9.3 | 12.0 | 13.0 | 9.0 | 10.0 |
ONT2 | 11 | 9.5 | M | 17.0 | 17.0 | 16.0 | 15.3 | 9.0 | 12.0 | 12.0 | 12.0 |
ONT3 | 6 | 6.5 | F | 16.3 | 15.7 | 16.3 | 14.7 | 15.0 | 9.0 | 15.0 | 14.7 |
ONT4 | 6 | 4.7 | F | 10.0 | 10.0 | 10.0 | 10.0 | 9.0 | 12.0 | NA | NA |
Table 2. Results of Retinal Function Testing
Table 2. Results of Retinal Function Testing
| 1 wk Post ONT (%) | 2 wk Post ONT (%) | P | | Control COV (%) |
| | | Treatment (ONT) | Time–Treatment Interaction | |
mfERG | | | | | |
N1 | −33 | −19 | 0.0618 | 0.0465 | 16 |
P1 | −43 | −26 | 0.0052 | 0.0041 | 12 |
N2 | −56 | −31 | 0.1082 | 0.1254 | 23 |
HFC | −65 | −66 | 0.0176 | 0.0040 | 18 |
PERG | | | | | |
P50 | −49 | −39 | 0.1343 | 0.1468 | 15 |
N95 | −70 | −76 | 0.0069 | 0.0037 | 13 |
ffERG | | | | | |
a-wave | −10 | −4 | 0.2384 | 0.0355 | 28 |
b-wave | −21 | −24 | 0.0311 | 0.0359 | 17 |
OP’s | −21 | −33 | 0.1000 | 0.0716 | 13 |
PhNR | −44 | −48 | 0.0053 | 0.0003 | 21 |
The authors thank Roger A. Dailey, MD, and Leonard A. Levin, MD, PhD, for helpful consultation and assistance toward optimization of lateral orbitotomy for optic nerve transection.
ZhouQ, KnightonRW. Light scattering and form birefringence of parallel cylindrical arrays that represent cellular organelles of the retinal nerve fiber layer. Appl Opt. 1997;36:2273–2285.
[CrossRef] [PubMed]HuangXR, KnightonRW. Linear birefringence of the retinal nerve fiber layer measured in vitro with a multispectral imaging micropolarimeter. J Biomed Opt. 2002;7:199–204.
[CrossRef] [PubMed]HuangXR, KnightonRW. Microtubules contribute to the birefringence of the retinal nerve fiber layer. Invest Ophthalmol Vis Sci. 2005;46:4588–4593.
[CrossRef] [PubMed]FortuneB, WangL, CullG, CioffiGA. Intravitreal colchicine causes decreased RNFL birefringence without altering RNFL thickness. Invest Ophthalmol Vis Sci. 2008;49:255–261.
[CrossRef] [PubMed]MinzenbergM, BerkelaarM, BrayG, McKerracherL. Changes in retinal ganglion cell axons after optic nerve crush: neurofilament expression is not the sole determinant of calibre. Biochem Cell Biol. 1995;73:599–604.
[CrossRef] [PubMed]McKerracherL, EssagianC, AguayoAJ. Temporal changes in beta-tubulin and neurofilament mRNA levels after transection of adult rat retinal ganglion cell axons in the optic nerve. J Neurosci. 1993;13:2617–2626.
[PubMed]HoffmanPN, PollockSC, StriphGG. Altered gene expression after optic nerve transection: reduced neurofilament expression as a general response to axonal injury. Exp Neurol. 1993;119:32–36.
[CrossRef] [PubMed]KashiwagiK, OuB, NakamuraS, TanakaY, SuzukiM, TsukaharaS. Increase in dephosphorylation of the heavy neurofilament subunit in the monkey chronic glaucoma model. Invest Ophthalmol Vis Sci. 2003;44:154–159.
[CrossRef] [PubMed]BalaratnasingamC, MorganWH, BassL, MatichG, CringleSJ, YuDY. Axonal transport and cytoskeletal changes in the laminar regions after elevated intraocular pressure. Invest Ophthalmol Vis Sci. 2007;48:3632–3644.
[CrossRef] [PubMed]BalaratnasingamC, MorganWH, BassL, CringleSJ, YuDY. Time-dependent effects of elevated intraocular pressure on optic nerve head axonal transport and cytoskeleton proteins. Invest Ophthalmol Vis Sci. 2008;49:986–999.
[CrossRef] [PubMed]VickersJC, SchumerRA, PodosSM, et al. Differential vulnerability of neurochemically identified subpopulations of retinal neurons in a monkey model of glaucoma. Brain Res. 1995;680:23–35.
[CrossRef] [PubMed]HuangXR, BaggaH, GreenfieldDS, KnightonRW. Variation of peripapillary retinal nerve fiber layer birefringence in normal human subjects. Invest Ophthalmol Vis Sci. 2004;45:3073–3080.
[CrossRef] [PubMed]WeinrebRN, DreherAW, ColemanA, QuigleyH, ShawB, ReiterK. Histopathologic validation of Fourier-ellipsometry measurements of retinal nerve fiber layer thickness. Arch Ophthalmol. 1990;108:557–560.
[CrossRef] [PubMed]WeinrebRN, BowdC, ZangwillLM. Scanning laser polarimetry in monkey eyes using variable corneal polarization compensation. J Glaucoma. 2002;11:378–384.
[CrossRef] [PubMed]CenseB, ChenTC, ParkBH, PierceMC, de BoerJF. In vivo depth-resolved birefringence measurements of the human retinal nerve fiber layer by polarization-sensitive optical coherence tomography. Opt Lett. 2002;27:1610–1612.
[CrossRef] [PubMed]CenseB, ChenTC, ParkBH, PierceMC, de BoerJF. Thickness and birefringence of healthy retinal nerve fiber layer tissue measured with polarization-sensitive optical coherence tomography. Invest Ophthalmol Vis Sci. 2004;45:2606–2612.
[CrossRef] [PubMed]RylanderHG, 3rd, KempNJ, ParkJ, ZaatariHN, MilnerTE. Birefringence of the primate retinal nerve fiber layer. Exp Eye Res. 2005;81:81–89.
[CrossRef] [PubMed]CenseB, MujatM, ChenTC, ParkBH, de BoerJF. Polarization-sensitive spectral-domain optical coherence tomography using a single line scan camera. Opt Express. 2007;15:2421–2431.
[CrossRef] [PubMed]MohammadiK, BowdC, WeinrebRN, MedeirosFA, SamplePA, ZangwillLM. Retinal nerve fiber layer thickness measurements with scanning laser polarimetry predict glaucomatous visual field loss. Am J Ophthalmol. 2004;138:592–601.
[CrossRef] [PubMed]MorganJE, WaldockA, JefferyG, CoweyA. Retinal nerve fibre layer polarimetry: histological and clinical comparison. Br J Ophthalmol. 1998;82:684–690.
[CrossRef] [PubMed]CenseB, ChenTC, ParkBH, PierceMC, de BoerJF. In vivo birefringence and thickness measurements of the human retinal nerve fiber layer using polarization-sensitive optical coherence tomography. J Biomed Opt. 2004;9:121–125.
[CrossRef] [PubMed]LalezaryM, MedeirosFA, WeinrebRN, et al. Baseline optical coherence tomography predicts the development of glaucomatous change in glaucoma suspects. Am J Ophthalmol. 2006;142:576–582.
[CrossRef] [PubMed]FortuneB, WangL, BuiBV, CullG, DongJ, CioffiGA. Local ganglion cell contributions to the macaque electroretinogram revealed by experimental nerve fiber layer bundle defect. Invest Ophthalmol Vis Sci. 2003;44:4567–4579.
[CrossRef] [PubMed]FortuneB, WangL, BuiBV, BurgoyneCF, CioffiGA. Idiopathic bilateral optic atrophy in the rhesus macaque. Invest Ophthalmol Vis Sci. 2005;46:3943–3956.
[CrossRef] [PubMed]RangaswamyNV, HoodDC, FrishmanLJ. Regional variations in local contributions to the primate photopic flash ERG: revealed using the slow-sequence mfERG. Invest Ophthalmol Vis Sci. 2003;44:3233–3247.
[CrossRef] [PubMed]ChoplinNT, ZhouQ, KnightonRW. Effect of individualized compensation for anterior segment birefringence on retinal nerve fiber layer assessments as determined by scanning laser polarimetry. Ophthalmology. 2003;110:719–725.
[CrossRef] [PubMed]GDxVCC Instrument Manual. RNFL. Analysis with GDxVCC: A Primer and Clinical Guide. 2004;Laser Diagnostic Technologies, Inc. San Diego, CA.
Qiao-GriderY, HungLF, KeeCS, RamamirthamR, SmithEL, 3rd. A comparison of refractive development between two subspecies of infant rhesus monkeys (Macaca mulatta). Vision Res. 2007;47:1668–1681.
[CrossRef] [PubMed]BellezzaAJ, RintalanCJ, ThompsonHW, DownsJC, HartRT, BurgoyneCF. Anterior scleral canal geometry in pressurised (IOP 10) and non-pressurised (IOP 0) normal monkey eyes. Br J Ophthalmol. 2003;87:1284–1290.
[CrossRef] [PubMed]HeickellAG, BellezzaAJ, ThompsonHW, BurgoyneCF. Optic disc surface compliance testing using confocal scanning laser tomography in the normal monkey eye. J Glaucoma. 2001;10:369–382.
[CrossRef] [PubMed]BurgoyneCF, MercanteDE, ThompsonHW. Change detection in regional and volumetric disc parameters using longitudinal confocal scanning laser tomography. Ophthalmology. 2002;109:455–466.
[CrossRef] [PubMed]BellezzaAJ, RintalanCJ, ThompsonHW, DownsJC, HartRT, BurgoyneCF. Deformation of the lamina cribrosa and anterior scleral canal wall in early experimental glaucoma. Invest Ophthalmol Vis Sci. 2003;44:623–637.
[CrossRef] [PubMed]BurgoyneCF, DownsJC, BellezzaAJ, HartRT. Three-dimensional reconstruction of normal and early glaucoma monkey optic nerve head connective tissues. Invest Ophthalmol Vis Sci. 2004;45:4388–4399.
[CrossRef] [PubMed]ChauhanBC, BlanchardJW, HamiltonDC, LeBlancRP. Technique for detecting serial topographic changes in the optic disc and peripapillary retina using scanning laser tomography. Invest Ophthalmol Vis Sci. 2000;41:775–782.
[PubMed]ChauhanBC, McCormickTA, NicolelaMT, LeBlancRP. Optic disc and visual field changes in a prospective longitudinal study of patients with glaucoma: comparison of scanning laser tomography with conventional perimetry and optic disc photography. Arch Ophthalmol. 2001;119:1492–1499.
[CrossRef] [PubMed]AndersonDR, HendricksonA. Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Invest Ophthalmol. 1974;13:771–783.
[PubMed]MincklerDS, BuntAH, KlockIB. Radioautographic and cytochemical ultrastructural studies of axoplasmic transport in the monkey optic nerve head. Invest Ophthalmol Vis Sci. 1978;17:33–50.
[PubMed]KarlssonJO, SjostrandJ. The effect of colchicine on the axonal transport of protein in the optic nerve and tract of the rabbit. Brain Res. 1969;13:617–619.
[CrossRef] [PubMed]BuntAH. Effects of vinblastine on microtubule structure and axonal transport in ganglion cells of the rabbit retina. Invest Ophthalmol. 1973;12:579–590.
[PubMed]AlbertsB, BrayD, LewisJ, RaffM, RobertsK, WatsonJD. Molecular Biology of the Cell. 1989; 2nd ed.Garland New York.
QuigleyH, AndersonDR. The dynamics and location of axonal transport blockade by acute intraocular pressure elevation in primate optic nerve. Invest Ophthalmol. 1976;15:606–616.
[PubMed]QuigleyHA, GuyJ, AndersonDR. Blockade of rapid axonal transport. Effect of intraocular pressure elevation in primate optic nerve. Arch Ophthalmol. 1979;97:525–531.
[CrossRef] [PubMed]QuigleyHA, AddicksEM. Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest Ophthalmol Vis Sci. 1980;19:137–152.
[PubMed]MartinKR, QuigleyHA, ValentaD, KielczewskiJ, PeaseME. Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma. Exp Eye Res. 2006;83:255–262.
[CrossRef] [PubMed]ViswanathanS, FrishmanLJ, RobsonJG, HarwerthRS, SmithEL, 3rd. The photopic negative response of the macaque electroretinogram: reduction by experimental glaucoma. Invest Ophthalmol Vis Sci. 1999;40:1124–1136.
[PubMed]ViswanathanS, FrishmanLJ, RobsonJG, WaltersJW. The photopic negative response of the flash electroretinogram in primary open angle glaucoma. Invest Ophthalmol Vis Sci. 2001;42:514–522.
[PubMed]RangaswamyNV, FrishmanLJ, DorotheoEU, SchiffmanJS, BahraniHM, TangRA. Photopic ERGs in patients with optic neuropathies: comparison with primate ERGs after pharmacologic blockade of inner retina. Invest Ophthalmol Vis Sci. 2004;45:3827–3837.
[CrossRef] [PubMed]HolderGE. Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis. Prog Retin Eye Res. 2001;20:531–561.
[CrossRef] [PubMed]RangaswamyNV, ZhouW, HarwerthRS, FrishmanLJ. Effect of experimental glaucoma in primates on oscillatory potentials of the slow-sequence mfERG. Invest Ophthalmol Vis Sci. 2006;47:753–767.
[CrossRef] [PubMed]ZhouW, RangaswamyN, KtonasP, FrishmanLJ. Oscillatory potentials of the slow-sequence multifocal ERG in primates extracted using the matching pursuit method. Vision Res. 2007;47:2021–2036.
[CrossRef] [PubMed]BushRA, SievingPA. A proximal retinal component in the primate photopic ERG a-wave. Invest Ophthalmol Vis Sci. 1994;35:635–645.
[PubMed]PaupooAA, MahrooOA, FriedburgC, LambTD. Human cone photoreceptor responses measured by the electroretinogram [correction of electoretinogram] a-wave during and after exposure to intense illumination. J Physiol. 2000;529(Pt 2)469–482.
[CrossRef] [PubMed]RobsonJG, SaszikSM, AhmedJ, FrishmanLJ. Rod and cone contributions to the a-wave of the electroretinogram of the macaque. J Physiol. 2003;547:509–530.
[CrossRef] [PubMed]